Inflammatory Bowel Disease and Risk of Rheumatoid Arthritis: A UK Biobank Cohort Study

Area of Science:

• Rheumatology
• Gastroenterology
• Immunology

Background:

• Inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) are common inflammatory conditions.
• Understanding the relationship between IBD and RA is crucial for patient health.
• The role of inflammatory mediators in this association requires further investigation.

Purpose of the Study:

• To explore the association between IBD and the subsequent risk of developing RA.
• To examine the mediating role of inflammatory markers, such as C-reactive protein (CRP), in the IBD-RA relationship.

Main Methods:

• Utilized UK Biobank data from 373,693 individuals.
• Employed Cox regression models to assess the risk of RA in patients with IBD.
• Conducted mediation analysis to evaluate the impact of inflammatory markers.

Main Results:

• Individuals with IBD showed a significantly higher risk of developing RA (HR 2.06, 95% CI 1.69-2.51).
• The association persisted after adjusting for confounders and was stronger in individuals with a low polygenic risk score for RA.
• Inflammatory markers like CRP explained a modest proportion (up to 9.56%) of the IBD-RA association.

Conclusions:

• IBD is associated with an increased risk of developing RA.
• The underlying mechanisms linking IBD and RA require further research.
• Identifying these mechanisms can help improve long-term health outcomes for patients with IBD.